HEMORIO

Rio de Janeiro, Rio de Janeiro 20211-030

0 studies enrolling now · 1 studies all time

What they study most

Children, Hemophilia A, Prophylaxis of Bleeding, Treatment of Bleeding

Studies at this site

• A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood — Completed